MOTS-c 40mg Protocol

Key Benefits

Mitochondria-derived peptide — supports cellular energy

Enhances mitochondrial function & biogenesis

Improves endurance, recovery & physical performance

Supports fat metabolism & insulin sensitivity

Daily subcutaneous injection with gradual titration

Reconstitution

13.33 mg/mL

Concentration

133.3 mcg

Per Unit (U-100)

7 days

Use Within

Gradual Titration — Once Daily (2-Week Steps)

Weeks 1–2200 mcg (0.2 mg)1.5 units

Weeks 3–4400 mcg (0.4 mg)3 units

Weeks 5–6600 mcg (0.6 mg)4.5 units

Weeks 7–8800 mcg (0.8 mg)6 units

Weeks 9–10+1,000 mcg (1.0 mg)7.5 units

MAX DAILY DOSE: 1,000 mcg (1.0 mg)

Cycle: 8–12 weeks active | Optional extension to 16 weeks

Reconstitution Steps

3.0 mL

Bacteriostatic (BAC) Water Needed

Add to the 40mg vial → final concentration 13.33 mg/mL

Sanitize

Swab both vial stoppers with fresh alcohol and let them dry.

Draw Water

Draw exactly 3.0 mL bacteriostatic (BAC) water with a sterile syringe.

Add Slowly

Inject the water down the inner vial wall — never directly onto the powder.

Dissolve

Gently swirl or roll — do not shake. Wait until fully clear.

Label & Store

Refrigerate at 36–46°F, date the vial, use within 7 days.

Supply Planning

Duration	MOTS-c Vials (40mg)	Syringes (U-100)	Alcohol Swabs
8 Weeks	~1 vial	56	112 (2 boxes)
12 Weeks	~2 vials	84	168 (2 boxes)
16 Weeks	~3 vials	112	224 (3 boxes)

Injection Schedule — Once Daily

EVERY DAY — ANY CONSISTENT TIME

Subcutaneous

90° (45° if lean), slow injection

Rotate Daily

Abdomen · Outer thighs · Upper arms

Storage

−4°F

Lyophilized powder

36–46°F

Reconstituted (7 days!)

No Shake

Swirl/roll to dissolve

Protect

From Light Always

Experimental compound — no completed human clinical trials. Document daily dose & injection site.